Browse Tag

Ophthalmic Drug and Devices

May 20, 2020May 20, 2020

Global Ophthalmic Drugs Market to Expand Modestly, on Back of Increasing FDA Approvals for Novel Drugs

The global ophthalmic drugs market is anticipated to grow moderately, at a CAGR of 4.2% during the forecast period (2020-2025). Visual impairments have increased across the world, owing to a multitude of factors. Varying in degree, visual impairments are a global health concern, affecting individuals physically

July 19, 2018

Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials

Asia-Pacific specialist CRO Novotech announced it has partnered with the Asian Eye

Pharmaceutical News

Global Ophthalmic Drugs Market to Expand Modestly, on Back of Increasing FDA Approvals for Novel Drugs

May 20, 2020May 20, 2020

The global ophthalmic drugs market is anticipated to grow moderately, at a CAGR of 4.2% during the forecast period (2020-2025). Visual impairments

Pharmaceutical News

Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials

July 19, 2018

Asia-Pacific specialist CRO Novotech announced it has partnered with the Asian Eye Institute, Inc (AEI), a private eye center in

Go toTop

<img src="http://www.pharmamirror.com/wp-content/uploads/2018/01/Pharma-Mirror.png" alt="Mobile Logo" width="330" height="77">

Ophthalmic Drug and Devices

Global Ophthalmic Drugs Market to Expand Modestly, on Back of Increasing FDA Approvals for Novel Drugs

Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials

Global Ophthalmic Drugs Market to Expand Modestly, on Back of Increasing FDA Approvals for Novel Drugs

Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials